Over-the-counter cough and cold medicines are “unproven and dangerous” for young children, according to
doctors and consumer advocates.
The experts urged US Food and Drug Administration officials to ban sales of the products, which include versions of Wyeth’s Dimetapp and Procter & Gamble Co.’s NyQuil, for children ages 2 to 6.
Other products also include Novartis AG’s Triaminic and Johnson & Johnson’s Tylenol and PediaCare.
“Cough and cold medications…have not been proven to be effective and they have clear risks. It is time for them to be reevaluated,” Dr. Wayne Snodgrass of the
University of Texas Medical Branch said at an FDA meeting.
Such products have been sold for decades and aim to combat runny noses, coughs, congestion, and other symptoms. But they can potentially increase the risk of stroke, seizures, and other complications, often because of dosing errors.
They also have never been proven to work, the doctors said.